Prospective Database for Colonic or Rectal Resection Surgery Patients
Launched by INSTITUT PAOLI-CALMETTES · Jan 8, 2021
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is set up to gather important information about patients who have undergone surgery for colon or rectal issues, particularly related to colorectal cancer. Colorectal cancer is a common type of cancer, affecting many men and women, and this study aims to learn more about the experiences and outcomes of patients after their surgeries.
To participate in this trial, you need to be at least 18 years old and have received treatment for colon or rectal surgery at the Paoli-Calmettes Institute. You also need to be part of a health insurance program. If you join the study, you’ll be contributing to valuable research that can help improve care for future patients. Although the trial is not yet recruiting participants, it's an important step in understanding how surgery impacts recovery and long-term health for those with colorectal disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients treated for colonic and / or rectal resection in the oncological digestive surgery department of the Paoli-Calmettes Institute,
- • 2. Patients over 18 years old,
- • 3. Affiliation to a social security scheme, or beneficiary of such a scheme.
About Institut Paoli Calmettes
Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials